These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 25668619)

  • 1. Clinical proteomics identifies urinary CD14 as a potential biomarker for diagnosis of stable coronary artery disease.
    Lee MY; Huang CH; Kuo CJ; Lin CL; Lai WT; Chiou SH
    PLoS One; 2015; 10(2):e0117169. PubMed ID: 25668619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD14+CD16+ monocytes in coronary artery disease and their relationship to serum TNF-alpha levels.
    Schlitt A; Heine GH; Blankenberg S; Espinola-Klein C; Dopheide JF; Bickel C; Lackner KJ; Iz M; Meyer J; Darius H; Rupprecht HJ
    Thromb Haemost; 2004 Aug; 92(2):419-24. PubMed ID: 15269840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary proteome profile predictive of disease activity in rheumatoid arthritis.
    Kang MJ; Park YJ; You S; Yoo SA; Choi S; Kim DH; Cho CS; Yi EC; Hwang D; Kim WU
    J Proteome Res; 2014 Nov; 13(11):5206-17. PubMed ID: 25222917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential urinary proteins to diagnose coronary heart disease based on iTRAQ quantitative proteomics.
    Sun H; Wang D; Liu D; Guo Z; Shao C; Sun W; Zeng Y
    Anal Bioanal Chem; 2019 Apr; 411(11):2273-2282. PubMed ID: 30806752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of urine proteome pattern analysis for its potential to reflect coronary artery atherosclerosis in symptomatic patients.
    von Zur Muhlen C; Schiffer E; Zuerbig P; Kellmann M; Brasse M; Meert N; Vanholder RC; Dominiczak AF; Chen YC; Mischak H; Bode C; Peter K
    J Proteome Res; 2009 Jan; 8(1):335-45. PubMed ID: 19053529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased proatherogenic monocyte-platelet cross-talk in monocyte subpopulations of patients with stable coronary artery disease.
    Czepluch FS; Kuschicke H; Dellas C; Riggert J; Hasenfuss G; Schäfer K
    J Intern Med; 2014 Feb; 275(2):144-54. PubMed ID: 24118494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of inflammatory signaling in monocytes from patients with coronary artery disease.
    Schirmer SH; Fledderus JO; van der Laan AM; van der Pouw-Kraan TC; Moerland PD; Volger OL; Baggen JM; Böhm M; Piek JJ; Horrevoets AJ; van Royen N
    J Mol Cell Cardiol; 2009 Feb; 46(2):177-85. PubMed ID: 19059264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary proteomic biomarkers to predict cardiovascular events.
    Brown CE; McCarthy NS; Hughes AD; Sever P; Stalmach A; Mullen W; Dominiczak AF; Sattar N; Mischak H; Thom S; Mayet J; Stanton AV; Delles C
    Proteomics Clin Appl; 2015 Jun; 9(5-6):610-7. PubMed ID: 25786980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum cyclin-dependent kinase 9 is a potential biomarker of atherosclerotic inflammation.
    Han Y; Zhao S; Gong Y; Hou G; Li X; Li L
    Oncotarget; 2016 Jan; 7(2):1854-62. PubMed ID: 26636538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of urinary methylated nucleosides of patients with coronary artery disease by high-performance liquid chromatography/electrospray ionization tandem mass spectrometry.
    Li Y; Yu H; Zhao W; Xu X; Zhou J; Xu M; Gao W; Yuan G
    Rapid Commun Mass Spectrom; 2014 Oct; 28(19):2054-8. PubMed ID: 25156594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urine proteomics in the diagnosis of stable angina.
    Neisius U; Koeck T; Mischak H; Rossi SH; Olson E; Carty DM; Dymott JA; Dominiczak AF; Berry C; Oldroyd KG; Delles C
    BMC Cardiovasc Disord; 2016 Apr; 16():70. PubMed ID: 27095611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of coronary artery disease using urinary proteomics.
    Wei D; Melgarejo JD; Van Aelst L; Vanassche T; Verhamme P; Janssens S; Peter K; Zhang ZY
    Eur J Prev Cardiol; 2023 Oct; 30(14):1537-1546. PubMed ID: 36943304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary CD14 as a potential biomarker for benign prostatic hyperplasia - discovery by combining MALDI-TOF-based biostatistics and ESI-MS/MS-based stable-isotope labeling.
    Cheng HL; Huang HJ; Ou BY; Chow NH; Chen YW; Tzai TS; Wu CJ; Chen SH
    Proteomics Clin Appl; 2011 Apr; 5(3-4):121-32. PubMed ID: 21322116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD14 promoter polymorphism (- 159C-->t) is not associated with myocardial infarction or coronary artery disease in patients with assumed high genetic risk.
    Haberbosch W; Unkelbach K; Schuster D; Gardemann A; Tillmanns H; Hölschermann H
    Thorac Cardiovasc Surg; 2009 Oct; 57(7):386-90. PubMed ID: 19795323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma Proteome Profiling of Coronary Artery Disease Patients: Downregulation of Transthyretin-An Important Event.
    Monu ; Kharb R; Sharma A; Chaddar MK; Yadav R; Agnihotri P; Kar A; Biswas S
    Mediators Inflamm; 2020; 2020():3429541. PubMed ID: 33299376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monocyte and macrophage subtypes as paired cell biomarkers for coronary artery disease.
    Arnold KA; Blair JE; Paul JD; Shah AP; Nathan S; Alenghat FJ
    Exp Physiol; 2019 Sep; 104(9):1343-1352. PubMed ID: 31264265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urine sample preparation in 96-well filter plates to characterize inflammatory and infectious diseases of the urinary tract.
    Yu Y; Pieper R
    Adv Exp Med Biol; 2015; 845():77-87. PubMed ID: 25355571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary proteomic biomarkers in coronary artery disease.
    Zimmerli LU; Schiffer E; Zürbig P; Good DM; Kellmann M; Mouls L; Pitt AR; Coon JJ; Schmieder RE; Peter KH; Mischak H; Kolch W; Delles C; Dominiczak AF
    Mol Cell Proteomics; 2008 Feb; 7(2):290-8. PubMed ID: 17951555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comprehensive proteomic profiling of urinary exosomes and the identification of early non-invasive biomarker in patients with coronary artery disease.
    Sharma P; Roy A; Dhamija RK; Bhushan S; Baswal K; Kulandaisamy R; Yadav S; Kumar S; Inampudi KK
    J Proteomics; 2024 Feb; 293():105059. PubMed ID: 38151158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary proteomic diagnosis of coronary artery disease: identification and clinical validation in 623 individuals.
    Delles C; Schiffer E; von Zur Muhlen C; Peter K; Rossing P; Parving HH; Dymott JA; Neisius U; Zimmerli LU; Snell-Bergeon JK; Maahs DM; Schmieder RE; Mischak H; Dominiczak AF
    J Hypertens; 2010 Nov; 28(11):2316-22. PubMed ID: 20811296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.